VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 57 filers reported holding VINCERX PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,166 | -50.3% | 37,054 | -37.2% | 0.00% | – |
| Q2 2023 | $76,747 | +86132.6% | 59,036 | -30.7% | 0.00% | – |
| Q1 2023 | $89 | +25.4% | 85,175 | +21.5% | 0.00% | – |
| Q4 2022 | $71 | -100.0% | 70,076 | -66.2% | 0.00% | – |
| Q3 2022 | $287,000 | -29.1% | 207,612 | -32.3% | 0.00% | – |
| Q2 2022 | $405,000 | +118.9% | 306,598 | +562.4% | 0.00% | – |
| Q1 2022 | $185,000 | -66.1% | 46,288 | -13.4% | 0.00% | – |
| Q4 2021 | $545,000 | -17.8% | 53,437 | +4.7% | 0.00% | – |
| Q2 2021 | $663,000 | -56.0% | 51,043 | -34.7% | 0.00% | -100.0% |
| Q1 2021 | $1,508,000 | – | 78,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |